Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Badada Ananthamurthy Savitha

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cureus|October 25, 2024
Comparison of Risk Stratification by CanAssist Breast Test Performed on Core Needle Biopsies Versus Surgical Specimens in Hormone Receptor-Positive, Her2-Negative Early Breast CancerBadada Ananthamurthy Savitha, Payal Shrivastava, Rahul Bhagat, et al.
Clinical Breast Cancer|September 26, 2025
CanAssist Breast Provides Additional Insightful Prognostic Information in Retrospective, Pooled Secondary Analysis in Clinically Low/ High-Risk Patients With HR+/HER2- EBCTejal Deepak Durgekar, Susmita Ghosh, Badada Ananthamurthy Savitha, et al.
Scientific Reports|August 19, 2025
Real-world data of CanAssist Breast- first immunohistochemistry and AI-based prognostic testTejal Deepak Durgekar, Manvi Sunder, Badada Ananthamurthy Savitha, et al.
Archives of Pathology & Laboratory Medicine|June 17, 2026
CanAssist Breast Risk Stratification in Multifocal/Multicentric Breast Cancer: To Test Each Focus or Not?Badada Ananthamurthy Savitha, Tejal Deepak Durgekar, Payal Shrivastava, et al.
Breast Cancer Research : BCR|April 14, 2023
Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trialXi Zhang, Aparna Gunda, Elma Meershoek-Klein Kranenbarg, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cureus|October 25, 2024
Comparison of Risk Stratification by CanAssist Breast Test Performed on Core Needle Biopsies Versus Surgical Specimens in Hormone Receptor-Positive, Her2-Negative Early Breast CancerBadada Ananthamurthy Savitha, Payal Shrivastava, Rahul Bhagat, et al.
Clinical Breast Cancer|September 26, 2025
CanAssist Breast Provides Additional Insightful Prognostic Information in Retrospective, Pooled Secondary Analysis in Clinically Low/ High-Risk Patients With HR+/HER2- EBCTejal Deepak Durgekar, Susmita Ghosh, Badada Ananthamurthy Savitha, et al.
Scientific Reports|August 19, 2025
Real-world data of CanAssist Breast- first immunohistochemistry and AI-based prognostic testTejal Deepak Durgekar, Manvi Sunder, Badada Ananthamurthy Savitha, et al.
Archives of Pathology & Laboratory Medicine|June 17, 2026
CanAssist Breast Risk Stratification in Multifocal/Multicentric Breast Cancer: To Test Each Focus or Not?Badada Ananthamurthy Savitha, Tejal Deepak Durgekar, Payal Shrivastava, et al.
Breast Cancer Research : BCR|April 14, 2023
Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trialXi Zhang, Aparna Gunda, Elma Meershoek-Klein Kranenbarg, et al.
Pageof 1